Page last updated: 2024-09-05

enzastaurin and valproic acid

enzastaurin has been researched along with valproic acid in 1 studies

Compound Research Comparison

Studies (enzastaurin)	Trials (enzastaurin)	Recent Studies (post-2010) (enzastaurin)	Studies (valproic acid)	Trials (valproic acid)	Recent Studies (post-2010) (valproic acid)
188	52	99	14,155	1,256	5,108

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Almasan, A; Bodo, J; Hsi, ED; Maciejewski, JP; Sedlak, J	1

Other Studies

1 other study(ies) available for enzastaurin and valproic acid

Article	Year
HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. Apoptosis : an international journal on programmed cell death, 2011, Volume: 16, Issue:9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Caspase 3; Caspase 7; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Fluorescent Antibody Technique; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Lymphoma; Sulfides; Tumor Suppressor Protein p53; Valproic Acid; Vorinostat	2011

Article

Year

HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells.

Apoptosis : an international journal on programmed cell death, 2011, Volume: 16, Issue:9

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Caspase 3; Caspase 7; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Fluorescent Antibody Technique; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Lymphoma; Sulfides; Tumor Suppressor Protein p53; Valproic Acid; Vorinostat

2011